Oral Presentations

Oral Presentations

OP1 ER STRESS PATHWAY ACTIVATION IN COPD: INSIGHTS FROM PBMC mRNA EXPRESSION STUDIES
OP2 ASSOCIATION BETWEEN ICS EXPOSURE AND MORTALITY AMONG COPD PATIENTS IN MALAYSIA: EXACOS-MY STUDY
OP3 ASTHMA AND SMALL AIRWAY DISEASE – A RELOOK AT DIAGNOSIS: SPIROMETRY VS IOS – PRELIMINARY DATA
OP4 EBUS-MEDIASTINAL CRYOBIOPSY VERSUS CONVENTIONAL EBUS-NEEDLE ASPIRATION: A 24 MONTHS RETROSPECTIVE COMPARATIVE STUDY IN UNIVERSITY OF MALAYA
OP5 COST-UTILITY ANALYSIS OF PALIVIZUMAB FOR THE PREVENTION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN OTHERWISE HEALTHY MALAYSIAN INFANTS BORN AT 29-31 WEEKS’ GESTATIONAL AGE (WGA)
OP6 ASSESSMENT OF THE INTERNATIONAL RISK SCORING TOOL FOR IDENTIFYING MODERATE-TO-LATE PRETERM INFANTS AT GREATEST RISK OF SEVERE RESPIRATORY SYNCYTIAL VIRUS INFECTION IN MALAYSIA

Thematic Oral Presentations (Adult)

OPA1 DIAGNOSTIC VALUE OF THE METHACHOLINE CHALLENGE TEST IN PATIENTS PREVIOUSLY TREATED FOR BRONCHIAL ASTHMA WITH A NEGATIVE BRONCHODILATOR REVERSIBILITY TEST: THE ALOR SETAR EXPERIENCE
OPA2 A NORTHERN MALAYSIAN PERSPECTIVE ON BIOLOGIC THERAPY’S CLINICAL RESPONSE AND REMISSION IN INDIVIDUALS WITH SEVERE ASTHMA
OPA3 SURVIVAL ACROSS DIFFERENT AETIOLOGIES OF INTERSTITIAL LUNG DISEASE (ILD) AND ITS BASELINE PREDICTORS IN A TERTIARY CENTRE IN MALAYSIA
OPA4 A COMPLEX DUO: UNVEILING LUNG CANCER IN INTERSTITIAL LUNG DISEASE
OPA5 CLINICAL OUTCOMES AND PROGNOSTIC FACTORS IN MYOSITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: INSIGHTS FROM FIVE-YEAR MULTICENTRE STUDY
OPA6 EXPANDING INTERSTITIAL LUNG DISEASE(ILD) BEYOND THE LUNG: A STUDY ON THYROID ANTIBODIES AND THYROID DYSFUNCTION IN PATIENTS WITH ILD
OPA7 CLINICAL CHARACTERISTICS OF PULMONARY HYPERTENSION PATIENTS IN A MALAYSIAN POPULATION: A 5 YEAR RETROSPECTIVE SINGLE CENTER STUDY
OPA8 BEYOND USUAL CASES: SETTING UP MULTIDISCIPLINARY TEAM MEETINGS (MDTS) WITH BEDSIDE AWAKE NASOENDOSCOPY IN SLEEP MEDICINE
OPA9 MANAGEMENT OF HEALTHCARE WORKERS WITH LATENT TB INFECTION: A SINGLE CENTRE EXPERIENCE
OPA10 DIAGNOSTIC VALUE AND SAFETY OF MEDICAL THORACOSCOPY FOR MALIGNANT PLEURAL EFFUSION
OPA11 PREDICTORS OF DRAINAGE DURATION AND TRAPPED LUNG IN THORACOSCOPIC BIOPSY-PROVEN PLEURAL TUBERCULOSIS: EARLY INSIGHTS FROM THE SAPTO STUDY
OPA12 LEVELS OF SQUAMOUS CELL CARCINOMA ANTIGEN AND INTERLEUKIN-6 IN NON-SMALL CELL LUNG CANCER PATIENTS BEFORE CHEMOTHERAPY
OPA13 CHARACTERISTIC OF ADENOCARCINOMA LUNG PATIENTS WITH ROS-1 MUTATION AMONG NORTH SUMATRA POPULATION
OPA14 PREVALENCE AND CLINICAL OUTCOMES OF VIRAL PNEUMONIA IN THE MALAYSIAN ADULT URBAN POPULATION
OPA15 PREDICTIVE FACTORS FOR LENGTH OF HOSPITAL STAY IN VIRAL PNEUMONIA: AN UNDERSTUDIED ADULT POPULATION IN MALAYSIA
OPA16 CHALLENGES AND CONTROVERSIES IN THE TREATMENT OF ENDOBRONCHIAL TUBERCULOSIS WITH CENTRAL AIRWAY OBSTRUCTION